Nomura Asset Management Co. Ltd. Sells 7,280 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Nomura Asset Management Co. Ltd. lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,398 shares of the company's stock after selling 7,280 shares during the quarter. Nomura Asset Management Co. Ltd.'s holdings in HCA Healthcare were worth $23,735,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. FMR LLC raised its stake in shares of HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company's stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. Lee Danner & Bass Inc. purchased a new position in HCA Healthcare in the second quarter valued at about $131,527,000. Darsana Capital Partners LP raised its holdings in shares of HCA Healthcare by 53.3% in the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company's stock worth $369,472,000 after purchasing an additional 400,000 shares during the period. Holocene Advisors LP grew its holdings in HCA Healthcare by 210.6% during the third quarter. Holocene Advisors LP now owns 306,796 shares of the company's stock valued at $124,691,000 after purchasing an additional 208,015 shares during the period. Finally, Argent Capital Management LLC lifted its position in shares of HCA Healthcare by 1,215.6% during the 2nd quarter. Argent Capital Management LLC now owns 160,275 shares of the company's stock valued at $51,493,000 after buying an additional 148,092 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent research reports. Morgan Stanley started coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They set an "equal weight" rating and a $427.00 price objective on the stock. TD Cowen reduced their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a "buy" rating for the company in a research note on Monday, October 28th. UBS Group lifted their price target on HCA Healthcare from $405.00 to $438.00 and gave the company a "buy" rating in a research report on Wednesday, August 14th. Wells Fargo & Company downgraded HCA Healthcare from an "equal weight" rating to an "underweight" rating and cut their target price for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, KeyCorp lowered their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating on the stock in a report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $380.29.

HCA Healthcare Price Performance

HCA traded down $1.56 during midday trading on Wednesday, hitting $315.23. The stock had a trading volume of 882,105 shares, compared to its average volume of 1,201,990. HCA Healthcare, Inc. has a 1 year low of $260.79 and a 1 year high of $417.14. The company has a market cap of $79.85 billion, a P/E ratio of 14.22, a price-to-earnings-growth ratio of 1.23 and a beta of 1.63. The business has a fifty day moving average of $360.32 and a 200 day moving average of $358.90. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.85%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business's stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company's stock, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,155 shares of company stock worth $5,608,990. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.